MRVI vs OXY · rev $117.3M vs rev $13.29B
Maravai Lifesciences Holdings Inc (MRVI) versus OXY (OXY) — a side-by-side from cached financials, not a winner call.
Maravai Lifesciences Holdings Inc (MRVI) is a biotechnology company listed on NASDAQ.
OXY (OXY) common stock.
Latest reported MRVI revenue for 2026-06-30 was $117.3M. Net income was -$16.1M. Revenue was up 78.1% from 2026-03-31 to 2026-06-30. MRVI currently screens at market cap $1.93B.
Latest reported OXY revenue for 2026-06-30 was $13.29B. Net income was $6.36B. OXY currently screens at market cap $0.
MRVI currently screens at market cap $1.93B. OXY currently screens at market cap $0.
Not investment advice. Open the MRVI and OXY stock pages for the full models.
Not investment advice.